Cesca Therapeutics announces commercial launch of its AXP II blood system | FierceBiotech
Mar 2, 2018 @ 13:59

Cesca Therapeutics, which specializes in regenerative medicine and offers a range of automated technologies for cell-based therapeutics, announced the commercial launch of its AXP II system.

Sourced through Scoop.it from: www.fiercebiotech.com

Leave a Reply